BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng Z, Xiang J, Liu H, Li J, Xu X, Sun G, Zheng R, Zhang S, Liu J, Yang S, Xu Q, Wen X, Yuan H, Sun H, Dai L. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c02002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu X, Poulsen KL, Wu L, Liu S, Miyata T, Song Q, Wei Q, Zhao C, Lin C, Yang J. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). Signal Transduct Target Ther 2022;7:287. [PMID: 35963848 DOI: 10.1038/s41392-022-01119-3] [Reference Citation Analysis]
2 Xiong Y, Chen YH, Li T, Xie JH, Zhou QL. Enantioselective Total Synthesis of (-)-Hamigeran F and Its Rearrangement Product. Org Lett 2022. [PMID: 35816023 DOI: 10.1021/acs.orglett.2c01997] [Reference Citation Analysis]
3 Zang Y, Tai L, Hu Y, Wang Y, Sun H, Wen X, Yuan H, Dai L. Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor. J Chem Inf Model 2022;62:3123-32. [PMID: 35679529 DOI: 10.1021/acs.jcim.2c00345] [Reference Citation Analysis]